SanMelix Laboratories

What SanMelix Laboratories does

SanMelix Laboratories, Inc. is a privately held cosmeceutical and medical formulation company headquartered in Hollywood, United States, operating with 1-10 employees. The company develops and commercializes patented formulations based on buckwheat honey, which it describes as the first and only U.S. company to do so for cosmeceutical and medical applications. Its product portfolio is organized into four categories: beauty and skincare (collagen regeneration, skin barrier strengthening) under the BEECure brand, footcare (dry and cracked heels/feet), OTC health (minor cuts, scrapes, severe sunburns), and custom hydrogel wound dressings, with a premium sub-brand called PRESTIGE positioned at the prestige cosmeceutical tier. The company is FDA 21 CFR Part 11 certified and claims formulation and manufacturing capability across cosmetic, Class 1/2 medical device, OTC, and Rx drug regulatory classifications.

The business runs a dual revenue model. On the consumer side, SanMelix sells branded products through its own e-commerce storefront and the Amazon marketplace, where it achieved Amazon Choice status within the first month of listing and accumulated 100+ five-star reviews. On the B2B side, it offers contract manufacturing and white-label services covering product and packaging design, formulation, FDA regulatory compliance, manufacturing, wholesaler/retailer distribution, and shipping/logistics control, targeting brand partners at masstige, prestige, high-end cosmetic, Class 1/2 medical device, and OTC/Rx drug price and regulatory tiers. Distribution spans Amazon, its own website, and a wholesaler/retailer network within the United States.

SanMelix is at an early commercial stage. The company has raised approximately $1.2 million cumulatively across known events, including a $1,067,805 round in April 2021, a $134,888 equity crowdfunding raise via StartEngine in January 2022, and a non-cash engagement with Newchip Accelerator in October 2020. It has received the Stevie Award for Best New Health and Pharmaceutical Product, Mom's Choice Awards for its after-sun and anti-itch lotions, and Amazon Choice recognition, but its operating base remains micro-cap. No revenue is disclosed.

Name

SanMelix Laboratories

Legal name

SanMelix Laboratories, Inc.

Website

https://sanmelixlaboratories.com

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

1–10 employees

Short description

SanMelix Laboratories develops patented buckwheat honey-based cosmeceutical formulations spanning skincare, footcare, OTC wound care, and hydrogel wound dressings. The company sells direct-to-consumer via Amazon and offers B2B contract manufacturing and white-label services for brand partners.

Ownership category

akta.pro rank

Product category

Cosmeceuticals

NAICS

Soap and Cleaning Compound Manufacturing (32561)

SIC

Perfumes, Cosmetics & Other Toilet Preparations (2844), Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Dermatology & Aesthetics Pharmaceuticals (HLAIAAAK)

akta.pro secondary industries

Value-Added Bee Products Manufacturing (Candles, Cosmetics, Supplements, Mead Ingredients) (AFAEAHAM), Professional/Backbar Skincare (Esthetician & Spa Use) (CRABAAAK)

Keywords

• Buckwheat honey formulations
• Cosmeceutical manufacturing
• Wound care products
• Skincare contract manufacturing
• OTC health products

Headquarters

HQ city

Hollywood

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Technology or R&D, Personnel, Marketing or Sales, Infrastructure

Revenue model

1. Product Sales (BEECure & PRESTIGE): Direct consumer sales of branded skincare, footcare, and OTC health products through e-commerce channels including Amazon and direct website sales.
2. Contract Manufacturing & White-Label Services: B2B services offering formulations or finished goods for partners seeking brand expansion at masstige, prestige, high-end cosmetic, Class 1/2 medical device, or OTC/Rx drug levels. Includes product/packaging design, manufacturing, science & botanical ingredients, FDA regulatory compliance, and shipping control.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels2 records

Core offering

SanMelix Laboratories develops and manufactures patented, buckwheat honey-based cosmeceutical and medical formulations sold under its BEECure and PRESTIGE consumer brands across skincare, footcare, OTC health (after-sun and anti-itch lotions), and custom hydrogel wound dressing categories. Beyond branded consumer products, the company provides B2B contract manufacturing and white-label services including product/packaging design, formulation, FDA regulatory compliance, and distribution support for partners at masstige, prestige, high-end cosmetic, Class 1/2 medical device, and OTC/Rx drug levels.

Product overview

SanMelix Laboratories is the first and only U.S. company to harness the potency of Buckwheat Honey to develop award-winning and patented formulations in the cosmeceutical and medical fields. The company's portfolio includes two main product brands: BEECure (offering skin and wound care solutions) and PRESTIGE (a premium product line), alongside specialized product categories covering Beauty (skin care formulations), Footcare (moisture-rich foot solutions), OTC Health (over-the-counter skin repair products), and Custom Hydrogel wound dressings. The company also offers contract manufacturing services for brand concept, packaging design, FDA regulations compliance, and wholesaler/retailer distribution support.

Differentiator

Problem solved

Functional benefit

Brands

• BEECure: Product brand for buckwheat honey-based skincare formulations.
• PRESTIGE

Products and services

• BEECure BEECure is SanMelix Laboratories' buckwheat honey-based skin and wound care product brand offering formulations for various skin conditions, sold to individual consumers through the SanMelix e-commerce storefront and Amazon marketplace.
• PRESTIGE PRESTIGE is SanMelix Laboratories' premium product line positioned at the prestige/cosmeceutical level within the company's branded portfolio, targeting high-end cosmetic and cosmeceutical consumers and partners.
• After-Sun Lotion SanMelix's award-winning after-sun lotion is an OTC health product designed to repair and soothe skin following sun exposure.
• Anti-Itch Lotion SanMelix's award-winning anti-itch lotion is an OTC health product that provides skin relief from itching and irritation.
• Custom Hydrogel Wound Dressings SanMelix's custom hydrogel wound dressings are proprietary hydrogel formulations that promote healing, provide moisture, and offer soothing relief to sensitive skin when used as wound dressings.
• Contract Manufacturing and White-Label Services SanMelix offers B2B contract manufacturing and white-label services — including brand concept, product/packaging design, formulation, FDA regulatory compliance, timeline management, wholesaler/retailer distribution, and shipping control — for partners seeking to expand their brand at masstige, prestige, high-end cosmetic, Class 1/2 medical device, or OTC/Rx drug levels.

Quantifiable outcome

• Achieved Amazon Choice status within first month of product launch
• +1 more outcomes

Segments4 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Scale indicators2 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• 100% Pure: 100% Pure is a natural and organic skincare and cosmetics brand selling through DTC, Amazon, and specialty retail. It is a direct peer to SanMelix's natural cosmeceutical positioning with overlapping distribution channels and target consumers.
• Medihoney (Integra LifeSciences): Medihoney produces medical-grade honey-based wound dressings and is the closest direct peer in the medical/honey wound care category. Both companies leverage honey's clinical properties for wound and skin healing applications, making Medihoney the most directly comparable competitor.
• Comvita: Comvita is a New Zealand-based company built around manuka honey health and skincare products, including wound care and cosmeceutical lines. It shares SanMelix's honey-as-active-ingredient thesis across beauty and medical applications, making it a closely comparable global peer.
• Wedderspoon: Wedderspoon markets manuka honey-based skincare and wellness products through DTC and retail channels. Like SanMelix, it positions bee-derived honey as the hero ingredient in premium personal care, sharing the bee-product cosmeceutical narrative and distribution model.
• Beekeeper's Naturals: Beekeeper's Naturals develops bee-based wellness and skincare products, including propolis and honey formulations, sold through DTC and major retail. It is a direct peer in the honey/bee-based cosmeceutical space with overlapping target consumers and channel strategy.
• Crown Laboratories: Crown Laboratories is a specialty dermatology company developing prescription and consumer skincare products. It shares SanMelix's positioning at the intersection of cosmeceuticals, OTC, and Rx dermatology, making it a relevant peer for SanMelix's regulated skincare ambitions.
• Derma E: Derma E is a natural skincare brand offering moisturizers, anti-aging, and specialty skincare through natural and mass retail channels. It is a direct peer in the natural cosmeceutical space with overlapping target consumers seeking botanical skincare solutions.

Broad incumbents

• EltaMD: EltaMD is a dermatologist-recommended skincare brand offering sun care, moisturizers, and post-procedure skincare through medical channels. It is a broad incumbent that competes for the same prestige/dermatology-oriented consumer that SanMelix targets with PRESTIGE.
• Burt's Bees: Burt's Bees is a mass-market natural personal care brand owned by Clorox, offering skincare, lip care, and body care with honey and beeswax formulations. It is a broad incumbent that overlaps with SanMelix's honey-based skincare positioning but operates at significantly greater scale and channel reach.

Emerging players

• Innovacyn: Innovacyn produces wound and skin care products, including hydrogels and cleansers for animal and human health. It overlaps with SanMelix's custom hydrogel wound care category and is a relevant emerging peer in the OTC wound care space.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/sanmelixlabs

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds3 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SanMelix Laboratories